TI
COGT icon

Trexquant Investment’s Cogent Biosciences COGT Stock Holding History

Trexquant Investment’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66M Sell
68,754
-38,689
-36% -$1.35M 0.02% 1068
2026
Q1 		$4.14M Buy
107,443
+51,337
+92% +$1.9M 0.03% 727
2025
Q4 		$1.99M Sell
56,106
-510,266
-90% -$14.3M 0.02% 993
2025
Q3 		$8.13M Buy
566,372
+65,329
+13% +$774K 0.08% 366
2025
Q2 		$3.6M Buy
501,043
+317,222
+173% +$1.76M 0.04% 654
2025
Q1 		$1.1M Sell
183,821
-93,702
-34% -$735K 0.01% 1060
2024
Q4 		$2.16M Buy
277,523
+179,958
+184% +$1.79M 0.03% 836
2024
Q3 		$1.05M Sell
97,565
-51,289
-34% -$499K 0.01% 1035
2024
Q2 		$1.25M Buy
148,854
+130,001
+690% +$986K 0.02% 925
2024
Q1 		$127K Sell
18,853
-58,549
-76% -$362K ﹤0.01% 1378
2023
Q4 		$455K Buy
77,402
+36,294
+88% +$278K 0.01% 1115
2023
Q3 		$401K Buy
+41,108
New +$488K 0.01% 1113
2023
Q1 		– Sell
-61,506
Closed -$711K – 1478
2022
Q4 		$711K Buy
61,506
+23,904
+64% +$296K 0.02% 775
2022
Q3 		$561K Buy
+37,602
New +$515K 0.02% 763
2021
Q4 		– Sell
-11,407
Closed -$96K – 1346
2021
Q3 		$96K Buy
+11,407
New +$87.4K 0.01% 1055
2021
Q1 		– Sell
-13,138
Closed -$148K – 1163
2020
Q4 		$148K Buy
+13,138
New +$144K 0.02% 937

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Trexquant Investment's COGT Position: Q2 2026 in Review

Trexquant Investment reduced its Cogent Biosciences (COGT) stake by 36% in Q2 2026, selling an estimated $1.35M and leaving 68,754 shares worth $2.66M. The position accounts for 0.02% of the portfolio, ranked #1068.

Trexquant Investment first reported a position in COGT in Q4 2020 and has held it in 16 quarters since. The position peaked at $8.13M in Q3 2025. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Trexquant Investment held 68,754 shares of Cogent Biosciences worth $2.66M as of Q2 2026.
  • Trexquant Investment sold 38,689 Cogent Biosciences shares in Q2 2026, an estimated $1.35M.
  • Cogent Biosciences made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1068 holding.
  • Trexquant Investment first reported a position in Cogent Biosciences in Q4 2020 and has held it in 16 quarters since.
  • Trexquant Investment's Cogent Biosciences position peaked at $8.13M in Q3 2025.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.